Charles E. Britten
Active 2016–2018
- 2
- Papers
- 308
- Citations
- 2
- h-index
- 2
- i10-index
Self-citations are included in these numbers.
Citations per year
Citations
Citation sources
Countries
This corpus build does not record which country the citing authors are in, so the country breakdown is not computed. The other breakdowns below are unaffected.
Institutions
- AbbVie (United States)11.9%
- Spirogen (United Kingdom)10.9%
- Institute of Oncology Research8.9%
- Johns Hopkins University8.1%
- Cornell University7.6%
- University of Miami6.1%
- Other46.4%
Fields
- Medicine85.6%
- Immunology and Microbiology5.3%
- Biochemistry, Genetics and Molecular Biology3.8%
- Chemistry3.8%
- Engineering0.8%
- Materials Science0.8%
Topics
- CAR-T cell therapy research25.6%
- HER2/EGFR in Cancer Research18.5%
- Monoclonal and Polyclonal Antibodies Research17.9%
- Lymphoma Diagnosis and Treatment12.5%
- Chronic Lymphocytic Leukemia Research3.8%
- Immune Cell Function and Interaction3.5%
- Other18.2%
Frequent coauthors
- Arnaud Tiberghien2
- Carin E.G. Havenith2
- David G. Williams2
- Francesca Zammarchi2
- François D’Hooge2
- John A. Hartley2
- Narinder Janghra2
- Patrick H. van Berkel2
- Peter Tyrer2
- Philip W. Howard2
- Teresa Marafioti2
- Ayse U. Akarca1
- Conor S. Barry1
- Jean-Noel Levy1
- Konstantinos Kiakos1
- Lauren Adams1
- Luke A. Masterson1
- Michael Flynn1
- Paul W.H.I. Parren1
- Simon Chivers1
- Simon Corbett1
All papers
Loading papers…
